Alps Advisors Inc Rocket Pharmaceuticals, Inc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$15.79 - $22.6 $17,305 - $24,769	-1,096 Reduced 2.05%	52,273 $895,000
Q4 2022 Feb 14, 2023	BUY	$15.5 - $22.76 $268,754 - $394,635	17,339 Added 48.12%	53,369 $1.04 Million
Q3 2022 Nov 14, 2022	SELL	$12.37 - $18.41 $37,406 - $55,671	-3,024 Reduced 7.74%	36,030 $575,000
Q2 2022 Aug 11, 2022	SELL	$7.96 - $16.64 $216,830 - $453,273	-27,240 Reduced 41.09%	39,054 $537,000
Q1 2022 May 16, 2022	SELL	$13.16 - $23.68 $109,004 - $196,141	-8,283 Reduced 11.11%	66,294 $1.05 Million
Q4 2021 Feb 09, 2022	SELL	$21.52 - $36.02 $73,017 - $122,215	-3,393 Reduced 4.35%	74,577 $1.63 Million
Q3 2021 Nov 15, 2021	SELL	$27.42 - $48.97 $140,746 - $251,363	-5,133 Reduced 6.18%	77,970 $2.33 Million
Q2 2021 Aug 11, 2021	SELL	$39.41 - $47.25 $1.13 Million - $1.35 Million	-28,669 Reduced 25.65%	83,103 $3.68 Million
Q1 2021 May 07, 2021	BUY	$43.34 - $65.91 $520,903 - $792,172	12,019 Added 12.05%	111,772 $4.96 Million
Q4 2020 Feb 03, 2021	BUY	$23.3 - $59.57 $684,367 - $1.75 Million	29,372 Added 41.73%	99,753 $5.47 Million
Q3 2020 Nov 04, 2020	SELL	$20.5 - $28.59 $99,732 - $139,090	-4,865 Reduced 6.47%	70,381 $1.61 Million
Q2 2020 Aug 05, 2020	SELL	$13.32 - $22.61 $309,623 - $525,569	-23,245 Reduced 23.6%	75,246 $1.58 Million
Q1 2020 May 06, 2020	SELL	$9.71 - $25.11 $28,887 - $74,702	-2,975 Reduced 2.93%	98,491 $1.37 Million
Q4 2019 Feb 07, 2020	BUY	$11.07 - $24.23 $1.12 Million - $2.46 Million	101,466 New	101,466 $2.31 Million
Q4 2018 Feb 04, 2019	SELL	$11.21 - $23.53 $786,773 - $1.65 Million	-70,185 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$18.5 - $25.49 $240,648 - $331,573	13,008 Added 22.75%	70,185 $1.73 Million
Q2 2018 Aug 02, 2018	BUY	$14.58 - $23.0 $833,640 - $1.32 Million	57,177 New	57,177 $1.12 Million

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

Rtw Investments, LP New York, NY

17.7M
Shares

$231 Million
5.21% of portfolio
Wellington Management Group LLP Boston, MA

11.2M
Shares

$147 Million
0.04% of portfolio
Black Rock Inc. New York, NY

6.19M
Shares

$80.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.54M
Shares

$72.2 Million
0.0% of portfolio
Westfield Capital Management CO LP Boston, MA

4.49M
Shares

$58.6 Million
0.39% of portfolio

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $987M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account